P-gp-IN-31
P-gp-IN-31 is a P-glycoprotein (P-gp) inhibitor with IC50 values of 0.42 μM for KB cells and 0.43 μM for MDR KBvin cells. P-gp-IN-31 can pass P-gp-mediated drug efflux mechanisms and shows collateral sensitivity via P-gp downregulation. P-gp-IN-31 inhibits cell proliferation, induces apoptosis and arrests the cell cycle at G2/M phase. P-gp-IN-31 can be used for the research of cancer, such as multidrug-resistant (MDR) malignancies[1].
Product Specifications
UNSPSC
12352005
Target
Apoptosis; P-glycoprotein
Related Pathways
Apoptosis; Membrane Transporter/Ion Channel
Field of Research
Cancer
Smiles
O=C1C=C(NC2=CC(F)=CC=C2F)OC3=C1C=CC(OC)=C3
Molecular Formula
C16H11F2NO3
Molecular Weight
303.26
References & Citations
[1]Chang YH, et al. Harnessing cell cycle intervention and evading P-glycoprotein efflux: natural product-inspired C2-aminophenyl chromones as dual modulators against multidrug-resistant cancer. Eur J Med Chem. 2025 Nov 15;298:117978.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog